from stage 4 high-
We are on the precipice of making major advances in the treatment of cancer that will see patients treated with targeted therapy. With the advent of immunotherapy (including vaccine treatments), plus genomic wide (DNA) sequencing, transcriptomics (RNA sequencing) and proteomics; cancer medicine is really being revolutionised. Personalised medicine will reduce toxicity and improve outcomes.
And it’s already here for neuroblastoma: NMTRC Dell Precision Medicine Study for Neuroblastoma
We hope and believe Charlie will be one of the last Aussie kids with neuroblastoma that will be subjected to so much toxic treatment that is currently considered the ‘standard of care’…